We previously reported on a set of compounds that are effective against isocitrate dehydrogenase 1 (IDH1) mutant glioma, including omacetaxine mepesuccinate ((OMA) formerly known as homoharringtonine). This evidence concerns the gene IDH1 and central nervous system cancer.